Product Brochure

Winclove introduces Ecologic® AAD

Format: PDF file | Document type: Product Brochure | Promoted Content

This content is provided by Winclove Probiotics, and any views and opinions expressed do not necessarily reflect those of

Winclove introduces Ecologic® AAD

Ecologic®​ AAD has been tested in a randomized, double-blind, placebo-controlled trial with healthy volunteers taking amoxicillin, performed by Maastricht University Medical Centre. The trial showed that Ecologic®​ AAD significantly reduced the risk of diarrhoea-like defecation.

Ecologic®​ AAD is recommended by the World Gastroenterology Organisation in their Global Guidelines. We have developed our unique Probioact® Technology​ which allows all formulations to contain carefully selected ingredients that contribute to stability, GI-survival and metabolic activity of the probiotic strains.

Latest content from Winclove Probiotics

Evidence-based study for a multispecies probiotic to prevent AAD in children

Paid for and in partnership with Winclove Probiotics

Preventing AAD in children through advances in probiotics

The risk of antibiotic-associated diarrhoea (AAD) in children has long been an ongoing medical conundrum. Could the findings of a three-year clinical study provide a breakthrough?

Related resources from Winclove Probiotics

Supplier info centre